Skip to main content

All Podcast Episodes

Oncology Data Advisor® · National Donor Day: How To Be the Match With Richa Thakur, MD, and Will Smith On February 14, Oncology Data Advisor is celebrating National Donor Day and recognizing the contributions of individuals who have given organ and tissue donations for patients in need. In this interview, Fellows Forum member Dr. Richa Thakur has a conversation with Will Smith, a High S...
Oncology Data Advisor® · Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward In this interview, Dr. Jason Mouabbi, OncData Editorial Board Member and Breast Medical Oncologist at MD Anderson Cancer Center, speaks with Dr. Ross Maclean and Michael Glover about the debate surrounding accelerated FDA approvals, including their benefits, risks, and ways that physicians, ...
Oncology Data Advisor® · National Cancer Prevention Month: Rising Trends and How to Combat Them In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel discussion about the rising incidence of cancer diagnoses, factors contributing to them, and how to counsel patients in light of these emerging trends...
Oncology Data Advisor® · Breaking Developments in Neuroendocrine Tumor Research: Dr. Samuel Kareff and Dr. Aman Chauhan In this Fellows Forum interview, Samuel Kareff, MD, MPH, interviews Aman Chauhan, MD, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester Comprehensive Cancer Center, about how he became involved in neuroendocrine cancer research, the lates...
Oncology Data Advisor® · World Cancer Day 2024 with Oncology Data Advisor In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular testing, clinical trial diversity, and patient advocacy worldwide....
Oncology Data Advisor® · Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. Matthew Hadfield sat down for a discussion on the challenges in diagnosis of gallbladder and bile duct cancers and the importance of genetic sequencin...
Oncology Data Advisor® · National Cancer Prevention Month With Stephen Freedland and William Aronson In honor of National Cancer Prevention Month, Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, sat down with Dr. William Aronson, Professor of Urology at the University of California, Los Angeles (UCLA) and Chief of Urologi...
Oncology Data Advisor® · Racial and Socioeconomic Disparities in the CLL Community Oncology Setting: Ira Zackon, MD At the recent 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor sat down with Ira Zackon, MD, a Senior Medical Director with Ontada, to discuss his abstract and presentation about racial and socioeconomic disparities experienced by patien...
Oncology Data Advisor® · Investigating Odronextamab for R/R FL and DLBCL in the ELM-2 Study: Sabarish Ayyappan, MD At the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor sat down with Sabarish Ayyappan, MD, the Director of Hematological Malignancies at the City of Hope Cancer Center, to discuss the ELM-2 study which investigated odronextamab for relapsed/...
Oncology Data Advisor® · Utilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD At the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor sat down with Jon Arnason, MD, a Lymphoma Clinical Trial Specialist at Beth Israel Deaconess Medical Center, to discuss his abstract and presentation regarding the ELM-2 trial which studied ...
Oncology Data Advisor® · Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD In this interview from the 2023 American Society of Hematology Annual Meeting, Richa Parikh, MD, a third-year Hematology/Oncology Fellow at Karmanos Cancer Institute, discusses her team's study investigating the role of diet in multiple myeloma and how its findings can be used to help gu...
Oncology Data Advisor® · Highlights of Multiple Myeloma Research Presented at ASH 2023: Urvi Shah, MD At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering C...
Oncology Data Advisor® · Real-World Outcomes of Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Swetha Kambhampati, MD At the recent American Society of Hematology (ASH) Annual Meeting, Swetha Kambhampati, an Assistant Professor in the Division of Lymphoma at City of Hope, sat down with Oncology Data Advisor to further discuss her presentationregarding real-world outcomes of brexuca...
Oncology Data Advisor® · Exploring Revumenib for KMT2-Rearranged Acute Leukemias in the AUGMENT Trial: Ibrahim Aldoss, MD Recently, at the American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor sat down with Ibrahim Aldoss, MD, an Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, to further discuss his present...
Oncology Data Advisor® · Streamlining the Pathology Workflow Through AI: Waqas Haque and Leif Honda of TriMetis This second episode of Oncology Data Advisor's podcast series, Exploring Artificial Intelligence in Oncology, features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based researc...
This second episode of Oncology Data Advisor's podcast series, Exploring Artificial Intelligence in Oncology, features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based research, development, and testing. Dr. Waqas Haque, member of the Oncology Data Advisor Fellows Forum, speaks with Mr. Honda abou...
Oncology Data Advisor® · Managing Acute Leukemias and Lymphomas When Patients Stay Local: Dipti Patel-Donnelly, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Dipti Patel-Donnelly, a Medical Oncology at Virginia Cancer Specialists, hosted a session highlighting how to optimize management when patients with hematologic malignancies stay local. In this podcast e...
Oncology Data Advisor® · Exploring Acalabrutinib ± Obinutuzumab for CLL in the ELEVATE-TN Study: Jeff Sharman, MD Recently, at the American Society of Hematology (ASH) Annual Meeting, Dr. Jeff P. Sharman, the Medical Director of Hematology Research for Sarah Cannon Research Institute and the US Oncology Network, presented the long-term follow up results from the ELEVATE-TN study,...
Oncology Data Advisor® · Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD In this interview from the American Society of Hematology (ASH) Annual Meeting, Dr. Richa Thakur, OncData Fellows Forum member and Hematology/Oncology Fellow at Northwell Health, discusses her poster presentation on end-of-life outcomes in patients with acute myeloi...
Oncology Data Advisor® · Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur At the 2023 American Society of Hematology (ASH) Annual Meeting, Dr. Rahul Banerjee, Editor in Chief of Oncology Data Advisor, sat down with Dr. Gurbakhash Kaur, an Assistant Professor of Medicine at the University of Texas (UT) Southwestern Medical Center, to di...
Oncology Data Advisor® · Real-World Outcomes of Brexuctabtagene Autoleucel for B-Cell ALL: Evandro Bezerra, MD Recently, at the American Society of Hematology (ASH) Annual Meeting, Dr. Evandro Bezerra, a Hematology Specialist at the Ohio State University Comprehensive Cancer Center, sat down with Oncology Data Advisor to discuss his team's research regarding real-world outcomes of brexu...
Oncology Data Advisor® · Investigating Therapies Targeting Cardiovascular Health in MDS: Diego Adrianzen Herrera, MD In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Diego Adrianzen Herrera, a Malignant Hematologist at the University of Vermont Medical Center, about his study investigating the impact of hypomethyl...
Oncology Data Advisor® · Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Jeffrey Matous, MD, a Member of the Colorado Blood Cancer Institute in Denver, Colorado, presented his team's research and results of the MonumenTAL-2 trial, which studied talquetamab plus pomalidomide in p...
Oncology Data Advisor® · Improving Diversity in Multiple Myeloma Clinical Trials: Craig Cole, MD At the recent American Society of Hematology (ASH) Annual Meeting, Craig Cole, MD, Assistant Professor at Karmanos Cancer Institute, sat down with Oncology Data Advisor to share his passion for improving diversity in multiple myeloma clinical trials. He discusses the efforts that are current...
Oncology Data Advisor® · Empowering Patients Through Shared Decision Making in Myelodysplastic Syndromes: Claire Saxton At the 2023 American Society of Hematology (ASH) Annual Meeting, Claire Saxton, Executive Vice President of Insights and Impact at Cancer Support Community, presented her team's study on communication that enables shared decision making in myelodysplastic syndromes (MD...
Oncology Data Advisor® · Mitigating the Effects of Neighborhood Disadvantage in Acute Myeloid Leukemia: Brittany Ragon, MD   At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Brittany Ragon, Adult Leukemia and Transplant Specialist at Levine Cancer Institute, sat down with Oncology Data Advisor to discuss her presentation on neighborhood disadvantages associate...
Oncology Data Advisor® · Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer With Jason Mouabbi, MD, and Carlos Doti, MD Recently, the FDA granted approval to capivasertib in combination with fulvestrant for patients with hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1...
Oncology Data Advisor® · Response Patterns of Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Hans Lee, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Hans Lee, the Director of Multiple Myeloma Clinical Research at MD Anderson, presented his team's research from the LINKER-MM1 study, which sought to evaluate response patterns of linvoseltamab for relap...
Oncology Data Advisor® · CLL Society: Paving the Way For CLL Patients and Survivors With Brian Koffman, MD CLL Society is a patient-centric, physician-curated nonprofit organization that prioritizes patient education, advocacy, and research for the chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) community. Dr. Brian Koffman co-founded the organization after being...
Oncology Data Advisor® · Patterns of Care With BTK Inhibitors for CLL/SLL in the Community Setting: David Andorsky, MD At the recent American Society of Hematology (ASH) Annual Meeting in San Diego, Dr. David Andorsky, MD, a Clinical Hematologist and Medical Oncologist at the Rocky Mountain Cancer Centers in Boulder, Colorado, presented his research and observations regarding patterns o...
Oncology Data Advisor® · A Mobile App to Address Sexual Dysfunction in HSCT Survivors: Areej El-Jawahri, MD After receiving hematopoietic stem cell transplantation (HSCT), many survivors experience issues with sexual dysfunction which can impact their quality of life. To address this challenge, Dr. Areej El-Jawahri, Director of the Bone Marrow Transplant Survivorship Program at Massachu...
Oncology Data Advisor® · Exploring Results of the IsKia Trial in Newly Diagnosed Multiple Myeloma: Annemiek Broijl, MD In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Dr. Annemiek Broijl, Hematologist at Erasmus MC Cancer Institute in the Netherlands, discusses the IsKia trial, of which she is the Co-Primary Investigator, and its unique primary end p...
Oncology Data Advisor® · Financial Hardship Experienced During Transplant in Myelodysplastic Syndromes: Christopher Su, MD At the recent American Society of Hematology (ASH) Annual Meeting in San Diego, Christopher Su, MD, a Hematologist at the Fred Hutchinson Cancer Center, presented his research regarding financial hardships experienced in the transplant setting for myelodysplastic sy...
Oncology Data Advisor® · Coping With Psychological Distress Prior to Hematopoietic Cell Transplantation: Richard Newcomb, MD Patients with hematologic malignancies undergoing hospitalization for hematopoietic cell transplantation experience significant psychological distress, and they cope in different ways. In this interview from the 2023 American Society of Hematology (ASH), Dr. Richa...
Oncology Data Advisor® · Evaluating Outpatient Teclistamab Administration in Multiple Myeloma: Robert Rifkin, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Robert Rifkin, MD, FACP, a Board-Certified Medical Oncologist and Hematologist at the Rocky Mountain Cancer Centers in Denver, Colorado, sat down with Oncology Data Advisor to discuss his study and present...
Oncology Data Advisor® · Advancing Inclusion for Blood Donation Systems for Marginalized Groups: Warren Fingrut, MD At the recent American Society of Hematology (ASH) Annual Meeting, Warren Fingrut, MD, a Transplant and Cell Therapy Physician at MD Anderson Cancer Center and Founder and Director of Stem Cell Club, a donor recruitment organization based in Canada, sat down with Oncology ...
Oncology Data Advisor® · Nurse Navigation to Address Socioeconomic Disparities in ALL Treatment: Greg Knight, MD In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Greg Knight, MD, Clinical Assistant Professor of Medicine at Levine Cancer Institute, about his presentation on the impacts of nurse navigation and other sup...
Oncology Data Advisor® · Maintaining Functioning and QOL With Odronextamab for Follicular Lymphoma: Benoit Tessoulin, MD At the recent American Society of Hematology (ASH) Annual Meeting, Benoit Tessoulin, MD, PhD, Head of the Lymphoma Department at the Nantes University Hospital in France, sat down with Oncology Data Advisor to discuss the results from the ELM-2 study in which the effi...
Oncology Data Advisor® · Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan Recently, at the American Society of Hematology (ASH) Annual Meeting, Amer Zeidan, MBBS, MHS, the Interim Chief of Hematologic Malignancies Division at the Yale Cancer Center, presented his abstract regarding an investigation of oral decitabine and cedazuridine versus intravenous...
Oncology Data Advisor® · Epcoritamab for FL: Matt Hadfield, Alankrita Taneja, Tahi Ahmadi, Jacqueline Nielsen Recently, Genmab and AbbVie announced updated results of the phase 1/2 EPCORE™ NHL-1 trial of epcoritamab (epco) for patients with R/R follicular lymphoma. In this interview, Dr. Matthew Hadfield and Dr. Alankrita Taneja of the Fellows Forum speak with Dr. Tahi Ah...
Oncology Data Advisor® · Lowering Talquetamab Dosing Intensity to Improve Tolerability: Ajai Chari, MD At the recent American Society of Hematology (ASH) Annual Meeting, Ajai Chari, MD, Director of the Myeloma Program at the University of California, San Francisco, sat down with Oncology Data Advisor to discuss his abstract and presentation regarding updated results from the MonumenTAL-...
Recently, at the American Society of Hematology (ASH) Annual Meeting, Amer Zeidan, MBBS, MHS, the Interim Chief of Hematologic Malignancies Division at the Yale Cancer Center, presented his abstract regarding an investigation of oral decitabine and cedazuridine versus intravenous/subcutaneous hypomethylating agents (HMA) for patients with myelodysplastic syndromes (MDS). In this interview, Dr. Zei...
Oncology Data Advisor® · Predicting Immune-Related Adverse Events Through Machine Learning With Dr. Ofer Sharon of OncoHost In this first episode of Oncology Data Advisor's new podcast series, "Exploring Artificial Intelligence in Cancer Care," Dr. Waqas Haque and Dr. Matthew Hadfield of the OncData Fellows Forum engage in a discussion with Dr. Ofer Sharon, CEO of OncoHost. Dr. Sharon p...
Oncology Data Advisor® · Addressing Ethical Concerns Around Artificial Intelligence in Cancer Care: Andrew Hantel, MD In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Dr. Andrew Hantel, Instructor in Medicine at Harvard Medical School, shares more about his presentation on oncologists' perspectives on ethical implications of artificial intelligence (A...
New podcast series! Oncology Data Advisor is excited to launch our new series, "Exploring Artificial Intelligence in Oncology." Hosted by Waqas Haque, MD, MPH, Member of the Oncology Data Advisor Fellows Forum, this series will delve into the burgeoning roles and uses of AI in cancer care, from pathology to toxicity risk prediction to treatment recommendations and beyond.  Subscribe...
Oncology Data Advisor® · Investigating CD19-Targeted CAR T Cells for Autoimmune Diseases: Fabian Mueller, MD In this interview from the American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Fabian Mueller, the Principal Investigator at the Laboratory of Molecular Immunotherapeutics (LMIT) at the University Hospital of Erlangen, in Germany, about his stud...
Oncology Data Advisor® · Highlights From the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD At the recent San Antonio Breast Cancer Symposium (SABCS), numerous updates were presented which have the potential to improve treatment outcomes for patients with breast cancer. After returning from the meeting, Dr. Jason Mouabbi, Assistant Professor of Breast Medical Oncology a...
Oncology Data Advisor® · Expanding Access to Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Andre Goy, MD In this interview from the American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Andre Goy, Chair of the John Theurer Cancer Center and Hackensack University Medical Center, about his presentation on an expanded access study of brexucabtagen...
Oncology Data Advisor® · Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Alex Boucher, Director of the Pediatric and Adult Sickle Cell Programs at the University of Minnesota Medical School, about his presentation on racial discre...
Oncology Data Advisor® · Harnessing Machine Learning for MCL Risk Prognostication With Adrian Mosquera, MD, PhD In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Adrian Mosquera Orguiera, Clinical Hematologist at the University Hospital of Santiago de Compostela, about his research team's novel machine learning mod...
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. This podcast series features exclusive conversations on breaking data for novel therapies, technological innovations in hematology/oncology, efforts to re...
Oncology Data Advisor® · New Lung Cancer Screening Guidelines With Brian Whang Recently, the American Cancer Society recommended new lung cancer screening guidelines to shift the focus from quitting smoking, to helping all individuals who have smoked despite quitting 20 to 30 years prior. In this interview, Dr. Brian Whang, Medical Director of Lung Cancer Screening for Hartford Healthca...
Oncology Data Advisor® · TALAPRO-2 (Talazoparib + Enzalutamide) in Prostate Cancer: Stephen Freedland and Neeraj Agarwal In this interview, Oncology Data Advisor Editorial Board member Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, speaks with Dr. Neeraj Agarwal, Director of the Genitourinary (GU) Medical Oncology Group at Huntsman Cancer Institute, about hi...
Oncology Data Advisor® · Implementing Hepatic Artery Infusion Pump Programs With Sepideh Gholami, MD, MAS, FACS, FSSO Recently, Sepideh Gholami implemented a Hepatic Artery Infusion Pump Program at Northwell Health. In this interview, Dr. Gholami discusses what exactly a hepatic artery infusion pump is, its benefits, and how it will affect the future treatment landscape of cancers as a ...
Oncology Data Advisor® · Enzalutamide Approved for Nonmetastatic CSPC With Biochemical Recurrence: Stephen Freedland, MD The FDA recently granted approval to enzalutamide (enza) for the treatment of nonmetastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence, based on the results of the phase 3 EMBARK trial. Following the approval, Oncology Data Advisor Edito...
Oncology Data Advisor® · Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity, Evolving Treatment Concepts and New Data in Advanced Prostate Cancer. Since recording, a plethora of new data and treatment options have ...
Oncology Data Advisor® · Pancreatic Cancer Awareness Month: Improving Early Detection With Joseph Kalis, PharmD, BCOP This November, Oncology Data Advisor is honoring Pancreatic Cancer Awareness Month and helping to raise awareness about early detection in hopes of improving outcomes for patients with this disease. In this interview, Oncology Data Advisor Editorial Board member Joseph K...
Oncology Data Advisor® · Lung Cancer Awareness Month: Global Perspectives With MedNews Week and Oncology Data Advisor In this Lung Cancer Awareness Month video, members of Oncology Data Advisor and MedNews Week join forces to share global perspectives regarding treatment, equity, and patient advocacy in lung cancer.  ...
Recently, the FDA approved ivosidenib for adult patients with relapsed or refractory myelodysplastic syndromes (MDS) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. In this interview, Amir Fathi, MD, Director of the Leukemia Program at Massachusetts General Hospital, one of the leaders of the AG120-C-001 trial (NCT02074839), on which approval was based, sat down to further discuss t...
Oncology Data Advisor® · National Family Caregivers Month With Megan-Claire Chase During National Family Caregivers Month this November, Oncology Data Advisor is celebrating the caregivers of patients with cancer and advocating for increased awareness, support, and education regarding the caregiving experience. In this interview, Megan-Claire Chase, patient advocate and member of the On...
Oncology Data Advisor® · Great American Smokeout: The Link Between Smoking and Prostate Cancer With Stephen Freedland, MD In honor of the Great American Smokeout, Oncology Data Advisor sat down with Stephen Freedland, MD, the Director of the Center for Integrated Research in Cancer and Lifestyle at Cedars-Sinai Medical Center, to discuss the impact that smoking has on prostate cancer, a...
Oncology Data Advisor® · National Family Caregivers Month: The Nurse’s Perspective With Maria Badillo, MSN, RN, OCN®, CCRP During National Family Caregivers Month this November, Oncology Data Advisor is spotlighting not only the caregivers of patients with cancer, but also the oncology nurses who partner with them to help navigate the cancer care journey. In this interview, Ma...
Oncology Data Advisor® · Venetoclax for Multiple Myeloma in the Post-CANOVA Era: Rahul Banerjee, MD, FACP, and Andrew Yee, MD At the recent International Myeloma Society (IMS) Annual Meeting in Athens, Greece, results were presented of the CANOVA study of venetoclax for patients with relapsed/refractory multiple myeloma. After returning from the meeting, Dr. Rahul Banerjee, Assistant Pr...
Oncology Data Advisor® · Lung Cancer Awareness Month With Waqas Haque, Samuel Kareff, & Matthew Hadfield On the first day of Lung Cancer Awareness Month, members of Oncology Data Advisor's Fellows Forum joined forces to share recent research in lung cancer diagnosis and screening, the need to address disparities experienced by patients, and ways to raise awareness for patients, the ...
Oncology Data Advisor® · Updates on Bispecific Antibodies in Multiple Myeloma From IMS 2023: Rahul Banerjee and Shonali Midha At this year's International Myeloma Society (IMS) Annual Meeting, Dr. Shonali Midha, Instructor in Medicine at Harvard Medical School, presented real-world data of teclistamab for patients with relapsed/refractory multiple myeloma. After the meeting, Oncology Da...
Oncology Data Advisor® · The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu In this interview, Dr. Nagashree Seetharamu, MD, MBBS, a Professor in the Division of Hematology and Medical Oncology in the Department of Medicine at Hofstra Northwell Health, sat down to discuss the vital role that exercise takes in the cancer treatment and recovery process. As well, ...
Oncology Data Advisor® · Creating Educational Opportunities During Fellowship and Beyond With Sam Kareff and Matt Hadfield This Fellows Forum episode features Dr. Samuel Kareff and Dr. Matthew Hadfield in a discussion about unique ways to create educational opportunities during Hematology/Oncology Fellowship, including board exam preparation, methods for teaching residents and other fel...
Oncology Data Advisor® · Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for TNBC At this year's European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, Dr. Kevin Kalinsky, Director of the Glenn Family Breast Center at Winship Cancer Institute of Emory University, presented the results of real-world use patterns, effectiveness, and tol...
Oncology Data Advisor® · Reframing the Conversation in Metastatic Breast Cancer With Janie Metsker, RN, BSN, CN-BN For patients with metastatic breast cancer (MBC), Breast Cancer Awareness Month can sometimes be demoralizing in light of pervasive public messaging about finding a cure and embracing survivorship. In this interview, Janie Metsker, RN, BSN, CN-BN, Clinical Coordinator at St...
Oncology Data Advisor® · Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD In this interview, Dr. Brian Slomovitz, Director of Gynecologic Oncology at Mount Sinai Medical Center in Miami Beach, Florida, shares the results of the innovaTV 301 trial of tisotumab vedotin for patients with recurrent or metastatic cervical cancer, which we...
Oncology Data Advisor® · World Cancer Research Day With Samuel Kareff, Maria Badillo, Matthew Hadfield, and Alankrita Taneja In honor of World Cancer Research Day, members of Oncology Data Advisor's Editorial Board and Fellows Forum joined forces to share their passions for cancer research, discuss the recent and upcoming progress in their respective areas of study, and raise awareness ...
Oncology Data Advisor® · Additional Advances in Small Cell Lung Cancer Radiotherapy With Henry Park, MD, MPH Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health's CME/NCPD/CPE–approved podcast, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month...
Oncology Data Advisor® · Exploring Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield and Richa Thakur In this Oncology Data Advisor Fellows Forum interview, Dr. Matthew Hadfield, Medical Oncology Fellow at Brown University, and Dr. Richa Thakur, Hematology/Oncology Fellow at Northwell Health, explore the different types of educational opportunities available duri...
Oncology Data Advisor® · Twice Weekly, Biweekly, Somewhere in Between? Dosing in Myeloma: Rahul Banerjee and Gurbakhash Kaur In honor of Blood Cancer Awareness Month, Oncology Data Advisor Editorial Board Member Dr. Rahul Banerjee sat down with Gurbakhash Kaur, an Assistant Professor of Medicine at the University of Texas Southwestern Medical Center, to discuss updates and the advantage...
Oncology Data Advisor® · Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles In this interview, Thomas Powles, MD, MBBS, MRCP, Director of the Barts Cancer Center in London, sat down with Oncology Data Advisor to discuss the results of the EV-302 trial, a phase 3, open-label investigation of enfortumab vedotin plus pembrolizumab for previously untreated...
Oncology Data Advisor® · The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO In this Oncology Data Advisor Fellows Forum Interview, Dr. Matthew Hadfield, third-year Hematology/Oncology Fellow at Brown University, shares a comprehensive timeline of the history of immunotherapy and its emerging role in cancer treatment. Additionally, he shares ...
Oncology Data Advisor® · Self-Management Strategies for Peripheral Neuropathy With Connie Visovsky, PhD, RN, ACNP, FAAN In this interview for Breast Cancer Awareness Month, Dr. Connie Visovsky, Professor and Endowed Chair in Nursing Science at the University of South Florida, shares her research regarding exercise as a self-management strategy for chemotherapy-induced peripheral neuropa...
Oncology Data Advisor® · Finding Your Why: Reflecting on the Passion Behind Oncology Nursing With Lauren Ghazal, PhD, FNP-BC At the 2023 Oncology Nursing Society (ONS) Bridge Conference, Dr. Lauren Ghazal, Assistant Professor in the School of Nursing at the University of Rochester Medical School and Oncology Data Advisor Editorial Board member, gave the keynote presentation entitled "Fi...
Oncology Data Advisor® · Breast Cancer Awareness Month: Debunking Breast Cancer Myths With Jason Mouabbi, MD In this interview for Breast Cancer Awareness Month, Dr. Jason Mouabbi, Assistant Professor in the Department of Breast Oncology at the University of Texas MD Anderson Cancer Center, provides insightful answers to frequently asked questions and debunks common myths surrounding br...
Oncology Data Advisor® · Pink Fund: Financial Assistance During Breast Cancer Treatment With Founder Molly MacDonald For individuals with breast cancer, financial toxicity is a significant and often overwhelming part of the fight. Pink Fund is an organization which provides 90-day non-medical cost-of-living expenses, including housing, transportation, utilities, and insurance costs...
Oncology Data Advisor® · The Power of Interdisciplinary Oncology Collaboration: Oncology Data Advisor and MedNews Week In this panel discussion,Oncology Data Advisor and MedNews Week join forces to discuss the power of holding interdisciplinary conversations in oncology and the value of bringing together individuals from diverse backgrounds, locations, career stages, and specialtie...
Oncology Data Advisor® · Embracing Compassion in Health Care: The Power of Being Present With Marcus Engel, MS, CXCP, CSP In this interview, Marcus Engel, MS, CXCP, CSP, a renowned health care author and speaker, sat down with Oncology Data Advisor to share his personal experiences of receiving compassion in the health care system, its implication for patient care, and ways that medical...
Oncology Data Advisor® · Take a Loved One to the Doctor Day With Beth Sandy, MSN, CRNP In honor of Take a Loved One to the Doctor Day, Beth Sandy, MSN, CRNP, an Outpatient Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Center, and Editorial Board Member at Oncology Data Advisor, sat down to discuss the importance of advocating for our loved ones t...
Oncology Data Advisor® · Linvoseltamab for Multiple Myeloma: Results from IMS 2023 With Madhav Dhodapkar, MD At the International Myeloma Society (IMS) 2023 Annual Meeting and Exposition, Dr. Madhav Dhodapkar, Director of the Cancer Center at Emory University, presented the results of the LINKER-MM1 trial of linvoseltamab for relapsed/refractory multiple myeloma. Here, he further d...
Oncology Data Advisor® · Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD Recently, the FDA approved melphalan for liver-directed treatment of uveal melanoma. In this interview, Oncology Data Advisor Editorial Board member Dr. Richard Carvajal, Deputy Physician-in-Chief and Director of Medical Oncology at Northwell Health Cancer Institute in New York, d...
Oncology Data Advisor® · Waqas Haque WCRD Podcast In honor of World Cancer Research Day, Dr. Waqas Haque, a third-year Internal Medicine Resident at New York University (NYU) and Oncology Data Advisor Fellows Forum member, shares advice for residents and fellows who are interested in becoming involved in oncology research. Dr. Haque offers practical tips for finding a mentor, identifyin...
Oncology Data Advisor® · Pain Awareness Month With NIda Khan, MD, and Joseph Kalis, PharmD, BCOP This interview features Oncology Data Advisor Fellows Forum member Dr. Nida Khan, a Medical Oncology and Palliative Care Fellow at The Ohio State University, and Editorial Board member Dr. Joseph Kalis, Ambulatory Oncology Pharmacy Specialist at the University of Colorado Health, in a multid...
Oncology Data Advisor® · Prostate Cancer Awareness Month With Ulka Vaishampayan, MD In honor of Prostate Cancer Awareness Month, Oncology Data Advisor Editorial Board Member Ulka Vaishampayan, Professor of Internal Medicine at the University of Michigan Rogel Cancer Center, sat down to discuss the importance of bringing awareness to prostate cancer, up-to-date diagnostic techniques, and...
Oncology Data Advisor® · Raising Awareness of Prostate Cancer in Transgender Women: Farnoosh Nik-Ahd and Stephen Freedland This interview in honor of Prostate Cancer Awareness Month features Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, and Dr. Farnoosh Nik-Ahd, Urology Resident at the University of California, San Fran...
Oncology Data Advisor® · Understanding the Tumor Microenvironment for Oncology Drug Development With Jesus Garcia, PhD This interview features Jesus Garcia, PhD, a tissue and liquid biopsy expert who analyzes trial sponsors' clinical protocols and aids them in developing relevant biomarker strategies for their trials. Dr. Garcia discusses his passion for understanding the tumor microenv...
Oncology Data Advisor® · Appendix Cancer Awareness Month With Thomas Abrams, MD In honor of Appendix Cancer Awareness Month this August, Dr. Thomas Abrams, Editor-in-Chief of Oncology Data Advisor and Assistant Professor of Medicine at Harvard Medical School, sat down to explain the different subtypes and presentations of appendix cancer, factors he takes into consideration when making ...
Oncology Data Advisor® · National Immunization Awareness Month: Richa Thakur and Waqas Haque This Oncology Data Advisor Fellows Forum interview celebrates National Immunization Awareness Month, featuring Richa Thakur, MD, Hematology/Oncology (Heme/Onc) Fellow at Northwell Health, and Waqas Haque, MD, Internal Medicine Resident at New York University, in a discussion about the importance...
Oncology Data Advisor® · Investigating Epcoritamab for Follicular Lymphoma and Beyond With Reid Merryman, MD Epcoritamab, a bispecific CD20-directed CD3 T-cell engager, is currently being investigated in numerous settings for patients with non-Hodgkin lymphomas. Recently, results were presented at the European Hematology Association (EHA) Congress for Cohorts 2A and 2B of the phase 1/2 ...
Oncology Data Advisor® · Spotlighting Zolbetuximab for Gastric/Gastroesophageal Junction Adenocarcinoma: Kohei Shitara, MD In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Kohei Shitara, a Medical Oncologist at the National Cancer Center Hospital East in Japan, discusses his two abstracts investigating the efficacy of zolbetuximab in gastr...
Oncology Data Advisor® · Harnessing Precision Medicine in Oncology With Ofer Sharon, MD In this interview, Ofer Sharon, MD, the CEO of OncoHost, explains the unique opportunities for harnessing precision medicine in oncology, the unmet needs regarding biomarker development, and the potential of utilizing a multicomponent biomarker approach for understanding the mechanisms of therapy res...
Oncology Data Advisor® · Thinking Outside the Box: Integrating Wellness and Natural Medicine Into Pharmacy In this interview, Swathi Varanasi, PharmD, an integrative health pharmacist, shares her passion for incorporating wellness and natural medicine into pharmacy practice, including her pathway to studying integrative health, its specific roles for helping patients with cancer achieve...
Oncology Data Advisor® · Groundbreaking Results of Mirvetuximab Soravtansine for Ovarian Cancer With Kathleen Moore, MD Welcome to Oncology Data Advisor, a digital resource for the multidisciplinary cancer team. At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Kathleen Moore, MD, Associate Director of Clinical Research and Professor of Gynecologic Oncology at t...
Oncology Data Advisor® · Accelerated Brain Age in Survivors of Childhood Cancer With Nicholas Phillips, MD In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Nicholas Phillips, a Physician Scientist at St. Jude Children's Research Hospital, discusses his research investigating accelerated brain age and associated neurocognitive impairments e...
Oncology Data Advisor® · Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Thomas Hutson, Director of the Urologic Oncology Cancer Research and Treatment Center at Baylor Sammons Cancer Center, discusses the results of the CLEAR study, in which he and his co-inve...
Oncology Data Advisor® · Reducing Drug Waste Through Dose Rounding of Bevacizumab With Puneeth Indurlal, MD In this interview from the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, Dr. Puneeth Indurlal, Senior Director for Care Transformation at the US Oncology Network, discusses his team's abstract regarding dose rounding of bevacizumab, the potential for minimizing...